Genocea Biosciences (GNCA) Competitors

Genocea Biosciences (NASDAQ:GNCA) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.

Do insiders and institutionals hold more shares of GNCA or CALA?

0.6% of Genocea Biosciences shares are owned by institutional investors. 1.6% of Genocea Biosciences shares are owned by insiders. Comparatively, 6.6% of Calithera Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is GNCA or CALA more profitable?

Calithera Biosciences' return on equity of 0.00% beat Genocea Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genocea Biosciences	N/A	-182.88%	-62.76%
Calithera Biosciences	N/A	N/A	N/A

Which has better earnings & valuation, GNCA or CALA?

Genocea Biosciences has higher revenue and earnings than Calithera Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genocea Biosciences	$1.91M	0.00	-$33.20M	-$0.61	N/A
Calithera Biosciences	N/A	N/A	-$39.65M	N/A	N/A

Which has more risk & volatility, GNCA or CALA?

Genocea Biosciences has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -1.13, meaning that its stock price is 213% less volatile than the S&P 500.

Does the media refer more to GNCA or CALA?

In the previous week, Genocea Biosciences and Genocea Biosciences both had 1 articles in the media. Genocea Biosciences' average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genocea Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Calithera Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer GNCA or CALA?

Genocea Biosciences received 47 more outperform votes than Calithera Biosciences when rated by MarketBeat users. Likewise, 55.67% of users gave Genocea Biosciences an outperform vote while only 55.36% of users gave Calithera Biosciences an outperform vote.

Company	Underperform	Outperform
Genocea Biosciences	Outperform Votes 388 55.67%	Underperform Votes 309 44.33%
Calithera Biosciences	Outperform Votes 341 55.36%	Underperform Votes 275 44.64%

Summary

Genocea Biosciences beats Calithera Biosciences on 6 of the 9 factors compared between the two stocks.